Blog

Wafik S. El-Deiry: Pleased that SMURF-Therapeutics was able to submit a National Institutes of Health grant today

Photo of Wafik S. El-Deiry from vivo.brown.edu

Apr 8, 2024, 03:49

Wafik S. El-Deiry: Pleased that SMURF-Therapeutics was able to submit a National Institutes of Health grant today

Wafik S. El-Deiry,

“Pleased that SMURF-Therapeutics was able to submit a National Institutes of Health grant today. This is a milestone for any startup no matter what happens next! Thankful to Brown University for supporting the efforts.”

No alternative text description for this image

Source: Wafik S. El-Deiry/LinkedIn

Brown University cancer Emile Youssef Gary Olson Legorreta Cancer Center National Institutes of Health OncoDaily Oncology SMURF-Therapeutics Wafik S. El-Deiry

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

One Hand Gives, Another Takes? Trump, Musk, Congress and Childhood Cancer Research Funding

Fabrice André has been elected as the President of the ESMO for the term 2025-2026

Special Coverage